Condurango (Gonolobus condurango) Extract Activates Fas Receptor and Depolarizes Mitochondrial Membrane Potential to Induce ROS-dependent Apoptosis in Cancer Cells in vitro -CE-treatment on HeLa: a ROS-dependent mechanism-
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Condurango (Gonolobus condurango) extract is used by complementary and alternative medicine (CAM) practitioners as a traditional medicine, including homeopathy, mainly for the treatment of syphilis. Condurango bark extract is also known to reduce tumor volume, but the underlying molecular mechanisms still remain unclear. Methods: Using a cervical cancer cell line (HeLa) as our model, the molecular events behind condurango extract’s (CE’s) anticancer effect were investigated by using flow cytometry, immunoblotting and reverse transcriptase-polymerase chain reaction (RT-PCR). Other included cell types were prostate cancer cells (PC3), transformed liver cells (WRL-68), and peripheral blood mononuclear cells (PBMCs). Results: Condurango extract (CE) was found to be cytotoxic against target cells, and this was significantly deactivated in the presence of N-acetyl cysteine (NAC), a scavenger of reactive oxygen species (ROS), suggesting that its action could be mediated through ROS generation. CE caused an increase in the HeLa cell population containing deoxyribonucleic acid (DNA) damage at the G zero/Growth 1 (G0/G1) stage. Further, CE increased the tumor necrosis factor alpha (TNF-α) and the fas receptor (FasR) levels both at the ribonucleic acid (RNA) and the protein levels, indicating that CE might have a cytotoxic mechanism of action. CE also triggered a sharp decrease in the expression of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB ) both at the RNA and the protein levels, a possible route to attenuation of B-cell lymphoma 2 (Bcl-2), and caused an opening of the mitochondrial membrane’s permeability transition (MPT) pores, thus enhancing caspase activities. Conclusion: Overall, our results suggest possible pathways for CE mediated cytotoxicity in model cancer cells.
Abstract
Objectives: Condurango (Gonolobus condurango) extract is used by complementary and alternative medicine (CAM) practitioners as a traditional medicine, including homeopathy, mainly for the treatment of syphilis. Condurango bark extract is also known to reduce tumor volume, but the underlying molecular mechanisms still remain unclear. Methods: Using a cervical cancer cell line (HeLa) as our model, the molecular events behind condurango extract’s (CE’s) anticancer effect were investigated by using flow cytometry, immunoblotting and reverse transcriptase-polymerase chain reaction (RT-PCR). Other included cell types were prostate cancer cells (PC3), transformed liver cells (WRL-68), and peripheral blood mononuclear cells (PBMCs). Results: Condurango extract (CE) was found to be cytotoxic against target cells, and this was significantly deactivated in the presence of N-acetyl cysteine (NAC), a scavenger of reactive oxygen species (ROS), suggesting that its action could be mediated through ROS generation. CE caused an increase in the HeLa cell population containing deoxyribonucleic acid (DNA) damage at the G zero/Growth 1 (G0/G1) stage. Further, CE increased the tumor necrosis factor alpha (TNF-α) and the fas receptor (FasR) levels both at the ribonucleic acid (RNA) and the protein levels, indicating that CE might have a cytotoxic mechanism of action. CE also triggered a sharp decrease in the expression of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB ) both at the RNA and the protein levels, a possible route to attenuation of B-cell lymphoma 2 (Bcl-2), and caused an opening of the mitochondrial membrane’s permeability transition (MPT) pores, thus enhancing caspase activities. Conclusion: Overall, our results suggest possible pathways for CE mediated cytotoxicity in model cancer cells.
참고문헌 (26)
- Sudhakar A, "History of cancer, ancient and modern treatment methods", J Cancer Sci Ther, 1(2), pp.1~4 (2009)
- Hayden EC, "Cutting off cancer’s supply lines", Nature, 458(7239), pp.686~687 (2009)
- Zhang G, "Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy", Curr Mol Med, 12(2), pp.163~176 (2012)
- Troselj KG, "Curcumin in combined cancer therapy", Curr Pharm Des, 20(42), pp.6682~6696 (2014)
- Yao S, "Polyoxypregnane steroids from the stems of Marsdenia tenacissima", J Nat Prod, 77(9), pp.2044~2053 (2014)
- Ye B, "Anti-tumor activity and relative mechanism of ethanolic extract of Marsdenia tenacissima (Asclepiadaceae) against human hematologic neoplasm in vitro and in vivo", J Ethnopharmacol, 153(1), pp.258~267 (2014)
- Huang Z, "Studies on the anti-angiogenic effect of Marsdenia tenacissima extract in vitro and in vivo", Oncol Lett, 5(3), pp.917~922 (2013)
- Bishayee K, "Condurango-glycoside-A fraction of Gonolobus condurango induces DNA damage associated senescence and apoptosis via ROS-dependent p53 signalling pathway in HeLa cells", Mol Cell Biochem, 382(1-2), pp.173~183 (2013)
- Hayashi K, "Antitumor active glycosides from Condurango cortex", Chem Pharm Bull, 28(6), pp.1954~1958 (1980)
- pyrene-induced Lung Cancer of Rats, "Journal of Pharmacopuncture", 2014, 7~17, pp.대한약침학회, http:
- Chen J, "Identification of polyoxypregnane glycosides from the stems of Marsdenia tenacissima by high-performance liquid chromatography", tandem mass spectrometry, 2008, pp.77(1), 152~159
- Ulmer AJ, "Isolation and subfractionation of human peripheral blood mononuclear cells(PBMC)by density gradient centrifugation on percoll", Immunobiology, 166(3), pp.238~250 (1984)
- Paul A, "Diarylheptanoid-myricanone isolated from ethanolic extract of Myrica cerifera shows anticancer effects on HeLa and PC3 cell lines: signalling pathway and drug-DNA interaction", J Integr Med, 11(6), pp.405~415 (2013)
- Paul A, "Chelidonine isolated from ethanolic extract of Chelidonium majus promotes apoptosis in HeLa cells through p38-p53 and PI3K", AKT signalling pathways, 2012, pp.10(9), 1025~1038
- Mao Z, "Replicatively senescent cells are arrested in G1 and G2 phases", Aging, 4(6), pp.431~435 (2012)
- Fulda S, "Cellular stress responses: cell survival and cell death", Int J Cell Biol, 2010 (2010)
- Hanahan D, "The hallmarks of cancer", Cell, 100(1), pp.57~70 (2000)
- Lee SH, "Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm", Cell Death Differ, 20(1), pp.64~76 (2013)
- Rieger AM, "Modified annexin V", propidium iodide apoptosis assay for accurate assessment of cell death, 2011, pp.50, 2597~
- Lichter P, "The human APO-1(APT)antigen maps to 10q23, a region that is syntenic with mouse chromosome 19", Genomics, 14(1), pp.179~180 (1992)
- Klopfer A, "Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95", Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway, 2004, pp.23(58), 9408~9418
- Roy S, "Cross-talk in cell death signaling", J Exp Med, 192(8), pp.21~26 (2000)
- Papa S, "Mechanisms of liver disease: crosstalk between the NF-κB and JNK pathways", Biol Chem, 390(10), pp.965~976 (2009)
- Fiandalo MV, "Caspase control: protagonists of cancer cell apoptosis", Exp Oncol, 34(3), pp.165~175 (2012)
- Murphy MP, "How mitochondria produce reactive oxygen species", Biochem J, 417(1), pp.1~13 (2009)
- Pucci B, "Cell cycle and apoptosis", Neoplasia, 2(4), pp.291~299 (2000)